| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/09/2008 | CN101217940A Glp-1类似物制剂 Glp-1 analog formulations |
| 07/09/2008 | CN101215601A Effectors of innate immunity determination |
| 07/09/2008 | CN101215544A Inflammation-inhibiting compounds |
| 07/09/2008 | CN101215326A Luffa acutangula protein 1 and coding gene thereof |
| 07/09/2008 | CN101215325A Antibiotic peptides, preparation method and application thereof |
| 07/09/2008 | CN101215324A Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes |
| 07/09/2008 | CN101214375A Improved vaccines |
| 07/09/2008 | CN101214374A Preparations with procoagulant and hemostasis function |
| 07/09/2008 | CN101214373A Pre-meal insulin dosage control method |
| 07/09/2008 | CN101214372A Construction method of protein vaccine for in vivo inducing autoantibody aiming at TNF-alpha molecule |
| 07/09/2008 | CN101214371A Application of human recombination protein PDCD5 in preparing tumor chemotherapy sensitizing medicine |
| 07/09/2008 | CN101214370A Polypeptide medicament for treating tumor caused by human papillomavirus type 16 or vaccine |
| 07/09/2008 | CN101214369A Polypeptide medicament for treating tumor caused by human papillomavirus type 18 or vaccine |
| 07/09/2008 | CN101214263A Method for preparing freeze-dried powder containing bacillus natto and nattokinase |
| 07/09/2008 | CN101214259A Pilose antler basic fibroblast growth factor (DEER FGF) extraction and preparation thereof |
| 07/09/2008 | CN101214249A Chaperone-based therapy for niemann-pick disease |
| 07/09/2008 | CN101214224A Recombination human interferon injection |
| 07/09/2008 | CN100400659C Component of bromelain |
| 07/09/2008 | CN100400658C New type human death resist protein, its coded sequence and use |
| 07/09/2008 | CN100400657C Phosphokinase and the usage thereof |
| 07/09/2008 | CN100400656C Novel bifunctional molecule of RGD staphylokinase, its preparation process and application |
| 07/09/2008 | CN100400548C Fusional protein with intensified activity of internal red-blood-cell formation element |
| 07/09/2008 | CN100400546C Cell surface molecule mediating cell adhesion and signal transmission |
| 07/09/2008 | CN100400101C Vaccines containing ribavirin and methods of use thereof |
| 07/09/2008 | CN100400099C Recombinant protein vaccine for preventing and treating human prostata cancer |
| 07/09/2008 | CN100400098C Medicine composition containing octreotide grains |
| 07/09/2008 | CN100400097C Insulin liquid formulations for nose administration |
| 07/09/2008 | CN100400096C Reduced glutathione eye medicinal preparation |
| 07/09/2008 | CN100400031C Powdery preparations and proecss for producing the same |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396918 IGF-I fusion polypeptides and therapeutic uses thereof |
| 07/08/2008 | US7396916 Antibody to a polypeptide overexpressed in tumors |
| 07/08/2008 | US7396914 SARS nucleic acids, proteins, antibodies, and uses thereof |
| 07/08/2008 | US7396912 Collagen production method |
| 07/08/2008 | US7396911 Preventing, treating, or ameliorating human immunodeficiency virus infection |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396908 OAF065alpha and OAF065beta polypeptides |
| 07/08/2008 | US7396907 Antibodies that bind PRO6182 polypeptides |
| 07/08/2008 | US7396906 Pro4399 Polypeptides |
| 07/08/2008 | US7396846 Growth hormone secretagogues |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 07/08/2008 | US7396821 Applying non-invasive external pressure against the skin of a limb of a mammal to impede blood flow; inserting a polynucleotide encoding a protein linked to a promoter into a blood vessel in vivo distal to the applied pressure; and administering immunosuppressive drugs |
| 07/08/2008 | US7396817 Reducing symptoms of viral disease, especially hepatitis B, and stimulating the immune system |
| 07/08/2008 | US7396816 Low-molecular weight peptides inhibiting ion channel activity |
| 07/08/2008 | US7396815 Cosmetic or pharmaceutical composition containing peptides |
| 07/08/2008 | US7396814 Metallopeptide compositions for treatment of sexual dysfunction |
| 07/08/2008 | US7396812 Administering muramyl tripeptide or a derivative to enhance immune response; particularly for treating gramnegative bacterial infections |
| 07/08/2008 | US7396811 Subcellular targeting of therapeutic proteins |
| 07/08/2008 | US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
| 07/08/2008 | US7396809 Methods and reagents for treating glucose metabolic disorders |
| 07/08/2008 | US7396682 Genetic engineered protein; joining mammals cells |
| 07/08/2008 | US7396681 Inducing an immune response by natural killer cells to increase cytolytic activity or stimulate cell proliferation by administering in or ex vivo a specific chaperone protein; treating cancerous, infectious and autoimmune diseases |
| 07/08/2008 | US7396664 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396652 Chemokine PANEC-2 polypeptides and compositions and methods related thereto |
| 07/08/2008 | US7396649 Measurement cystatins concentration; calibrating headache |
| 07/08/2008 | US7396644 Method of diagnosing and treating dentinogenesis imperfecta type II by using dentin sialophosphoprotein gene and coded product thereof |
| 07/08/2008 | US7396535 Therapy for obsessive compulsive head banging |
| 07/08/2008 | US7396528 Exposing harvested tissue to concentration of an expression vector encoding cytokine; transplanting to eye; improving graft healing |
| 07/08/2008 | CA2675451A1 Combination therapy with angiogenesis inhibitors |
| 07/08/2008 | CA2395077C Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/08/2008 | CA2372377C A novel inhibitor of beta amyloid cleavage enzyme |
| 07/08/2008 | CA2359354C Medicament for the treatment, prevention and diagnosis of infection due to chlamydia pneumoniae |
| 07/08/2008 | CA2339384C Improved method for targeted topical treatment of disease |
| 07/08/2008 | CA2327336C Aerosol composition |
| 07/08/2008 | CA2280770C Gene therapy for alleviating erectile dysfunction |
| 07/08/2008 | CA2265917C Method for using oligonucleotides having modified cpg dinucleosides |
| 07/08/2008 | CA2250712C Chimeric isoprenoid synthases and uses thereof |
| 07/08/2008 | CA2243948C Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 07/08/2008 | CA2221455C Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
| 07/08/2008 | CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 07/08/2008 | CA2203961C Storage-stable fibrinogen preparations |
| 07/08/2008 | CA2198706C Methods for the treatment of inflammatory joint disease |
| 07/08/2008 | CA2188029C Porphocyanine and cnc-expanded porphyrins |
| 07/08/2008 | CA2187444C Antirestenosis protein |
| 07/08/2008 | CA2187329C Pharmaceutical formulations for treating dust mite allergy |
| 07/08/2008 | CA2162587C Therapeutic inhibitor of vascular smooth muscle cells |
| 07/08/2008 | CA2150262C Multivalent and multispecific binding proteins, their manufacture and use |
| 07/08/2008 | CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/08/2008 | CA2136848C Pharmaceutically acceptable fixed-dried human blood platelets |
| 07/08/2008 | CA2132836C Immunization by inoculation of dna transcription unit |
| 07/08/2008 | CA2117782C Use of renin-angiotensin antagonist for reducing post myocardial infarct morbidity and mortality |
| 07/08/2008 | CA1341576C Diagnosis of retinoblastoma |
| 07/03/2008 | WO2008080153A2 A novel protein kinase c therapy for the treatment of acute lung injury |
| 07/03/2008 | WO2008080082A2 Methods for modulating set and uses thereof |
| 07/03/2008 | WO2008080045A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 07/03/2008 | WO2008080035A2 Randomly oriented, fgf-2- modified nanofiber device for use in spinal cord repair |
| 07/03/2008 | WO2008080009A2 Neuroprotection by blood flow stabilization |
| 07/03/2008 | WO2008079982A2 Liposome composition for targeting egfr receptor |
| 07/03/2008 | WO2008079976A2 Dimeric high affinity egfr constructs and uses thereof |
| 07/03/2008 | WO2008079973A2 Egfr binding peptides and uses thereof |
| 07/03/2008 | WO2008079805A1 Controlled release composition and process |
| 07/03/2008 | WO2008079760A2 Nanocomposite pigments in a topical cosmetic application |
| 07/03/2008 | WO2008079685A2 Lipase variants for pharmaceutical use |
| 07/03/2008 | WO2008079566A2 Compositions and methods of modulating cell growth and motility |
| 07/03/2008 | WO2008079400A2 Surgical applications for bmp binding protein |
| 07/03/2008 | WO2008079326A2 Methods for using and identifying modulators of delta-like 4 |
| 07/03/2008 | WO2008079314A2 Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity |
| 07/03/2008 | WO2008079270A2 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |